.
MergerLinks Header Logo

New Deal


Announced

Havea to acquire Biocyte.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Cosmetics

Domestic

Majority

Personal health

Friendly

France

beauty care

Acquisition

Private

Pending

Single Bidder

Synopsis

Edit

Havea, a natural healthcare company, agreed to acquire Biocyte, a French laboratory that is a pioneer in nutricosmetics. Financial terms were not disclosed. This acquisition will allow Havea, a major player in the food supplements industry, to continue its growth in China, where it is already present through the Vitavea and Biolane brands.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US